Cortical Excitability and Role of rTMS in Cannabis Use Disorder

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cannabis Use Disorder, Moderate Clinical Trial

Official title:
Cortical Excitability and Role of rTMS in Cannabis Use Disorder

Status Not yet recruiting

Clinical Trial Summary

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder

n/a

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04964739` - Gender/Sex & CUD Remission	N/A
Not yet recruiting	`NCT06225232` - Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study	Phase 2
Completed	`NCT04923230` - Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse	N/A
Completed	`NCT04902092` - Brain Exercise and Addiction Trial	N/A
Recruiting	`NCT05064319` - Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders	Phase 2
Active, not recruiting	`NCT04567394` - Cannabis Use Disorder Treatment Study	Phase 2